A clinical trial has led to the approval of a treatment for patients with a rare, muscle-weakening disease called GNE myopathy.
Geiger Mueller News Service
Geiger Mueller News Service
A clinical trial has led to the approval of a treatment for patients with a rare, muscle-weakening disease called GNE myopathy.